Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF Accum-1C- USD

An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.

XGEN assets under management is ‪6.13 M‬ EUR. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.

Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.

XGEN invests in stocks. See more details in our Analysis section.

XGEN expense ratio is 0.35%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.

No, XGEN doesn't pay dividends to its holders.

XGEN shares are issued by Deutsche Bank AG

XGEN follows the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100 Index - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

The fund started trading on Jul 12, 2022.